BioInc@NYMC Client, Retia Medical, Receives U.S. FDA Clearance For Cardiovascular Monitor
Retia Medical, LLC is the first client at New York Medical College’s BioInc@NYMC to obtain FDA approval for a biomedical device.
Jennifer Riekert, M.B.A.
Vice President of Communications and Strategic Initiatives
New York Medical College
(914) 594-4552
jennifer_riekert@nymc.edu
Valhalla, NY, – Specifically, Retia Medical has obtained U.S. Food and Drug Administration (FDA) 501(k) clearance for its innovative cardiovascular monitoring system, the Argos Hemodynamic Monitor. The device ensures cardiac output (blood flow) accuracy in a non-invasive, easier to use and less costly manner. BioInc@NYMC, a New York State-designated Innovation Hot Spot, is currently incubating multiple startups at the forefront of medical innovation. Retia Medical is one of the first companies to rely on BioInc@NYMC’s collaborative environment, state-of-the-art lab equipment and academic support to develop lifesaving technology.
Retia Medical is a medical device company focused on advancing the quality and clinical use of hemodynamic monitoring. Their latest advancement, the Argos CO Monitor, is now available for sale in the United States and is intended for use on patients above the age of 18.
“We are very proud of the work that BioInc@NYMC clients are producing every single day, from innovations in telehealth to pharmaceutical development,” said Deborah Novick, director of BioInc@NYMC. “The recent advancement from Retia Medical, is a reflection on the investment we have put into biological and medical innovation in the Hudson Valley. We look forward to future successes for Retia Medical and all BioInc@NYMC clients.
The unique features and key benefits of the Argos CO monitor include superior accuracy, ease of use and cost-effectiveness. The monitor, when equipped with the company’s proprietary Multi-Beat Analysis™ (MBA) Algorithm, guarantees outstanding CO monitoring performance, reliability and compatibility for enhanced hemodynamic management.
Launched in October 2014, BioInc@NYMC is the Hudson Valley’s only biotechnology incubator offering shared resources, turnkey wet lab space, and sponsored professional services to promising, high-potential entrepreneurs and start-ups. In addition to providing best-in-class infrastructure and operational services, BioInc@NYMC assists its members in refining their business strategies, conserving capital, building strong teams, and achieving development and funding milestones. BioInc@NYMC occupies a 10,000-square-foot wing of a 129,000-square-foot campus building.
Retia Medical
Retia Medical aims to advance the use of cardiac output (CO) monitoring to improve patient care by providing members of the critical care team with a more accurate, easy-to-use, and affordable hemodynamic monitor that supports confident, data-based decisions.
Retia brings together industry-leading expertise in physiology, signal processing, and computational algorithms to engineer innovative monitoring solutions that give clinicians up-to-the-minute data that they can rely on to make informed patient care decisions. Additionally, Retia is committed to offering more clinicians access to CO monitoring by reducing the cost and inconvenience that limit the use of traditional CO technologies to the most high-risk patients. For additional information, please visit www.retiamedical.com.
About the Argos Cardiac Output Monitor
Retia Medical designed the Argos Cardiac Output (CO) Monitor to provide members of the Critical Care team in the OR and ICU with a more accurate, intuitive and affordable hemodynamic monitor that supports confident, data-based patient care decision making.
Equipped with Retia’s proprietary MBA™ algorithm, which uses advanced signal processing to improve the model of circulation and enables accurate tracking of both fluid and pressor resuscitation, the Argos Monitor seamlessly combines accuracy, ease of use, EMR connectivity and cost-effectiveness.
New York Medical College
Founded in 1860, New York Medical College is one of the oldest and largest health sciences colleges in the country with nearly 1,500 students and 330 residents and clinical fellows, more than 2,600 faculty members and 23,200 living alumni. The College, which joined the Touro College and University System in 2011, is located in Westchester County, New York, and offers degrees from the School of Medicine, the Graduate School of Basic Medical Sciences, the School of Health Sciences and Practice, as well as a school of dental medicine and a school of nursing. NYMC provides a wide variety of clinical training opportunities for students, residents, and practitioners.